Pharmaceutical composition containing an antiviral effective Dihydrochinazolinderivat

The invention relates to pharmaceutical preparations, in particular for intravenous administration, the {8-fluoro-2- [4- (3-methoxyphenyl) piperazin-1-yl] -3- [2-methoxy-5- (trifluoromethyl) phenyl] -3 , 4-dihydroquinazolin-4-yl} acetic acid with, in combination with at least one excipient selected from the cyclodextrins, lysine and arginine include, processes for their preparation and their use for the treatment and / or prophylaxis of diseases, in particular their use preferably as an antiviral agent Cytomegalieviren.